Laboratorios Farmaceuticos Rovi, S.A. (BME: ROVI)
Spain
· Delayed Price · Currency is EUR 61.40
+0.45 (0.74%)
Dec 20, 2024, 5:35 PM CET
BME: ROVI Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 3,141 | 3,213 | 1,925 | 4,138 | 2,099 | 1,351 | Upgrade
|
| Market Cap Growth | 33.63% | 66.93% | -53.49% | 97.10% | 55.36% | 39.84% | Upgrade
|
| Enterprise Value | 3,261 | 3,223 | 1,902 | 4,066 | 2,139 | 1,353 | Upgrade
|
| Last Close Price | 61.40 | 59.57 | 34.80 | 70.29 | 35.91 | 23.03 | Upgrade
|
| PE Ratio | 19.86 | 18.86 | 9.64 | 27.03 | 34.38 | 34.41 | Upgrade
|
| Forward PE | 18.56 | 19.76 | 12.76 | 25.69 | 30.76 | 32.13 | Upgrade
|
| PS Ratio | 4.10 | 3.87 | 2.35 | 6.38 | 5.00 | 3.54 | Upgrade
|
| PB Ratio | 5.97 | 5.91 | 3.69 | 8.79 | 5.62 | 4.19 | Upgrade
|
| P/TBV Ratio | 7.10 | 6.28 | 3.92 | 9.42 | 6.18 | 4.74 | Upgrade
|
| P/FCF Ratio | 47.69 | 54.04 | 10.30 | 37.88 | 278.47 | - | Upgrade
|
| P/OCF Ratio | 29.02 | 28.37 | 8.10 | 27.69 | 44.79 | - | Upgrade
|
| PEG Ratio | 1.69 | 13.17 | 1.42 | 0.84 | 0.95 | 0.68 | Upgrade
|
| EV/Sales Ratio | 4.08 | 3.89 | 2.33 | 6.27 | 5.09 | 3.55 | Upgrade
|
| EV/EBITDA Ratio | 13.66 | 13.54 | 7.01 | 20.68 | 23.87 | 24.41 | Upgrade
|
| EV/EBIT Ratio | 15.35 | 14.69 | 7.50 | 22.57 | 28.55 | 32.19 | Upgrade
|
| EV/FCF Ratio | 49.51 | 54.22 | 10.18 | 37.22 | 283.73 | - | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.12 | 0.14 | 0.16 | 0.20 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 0.54 | 0.27 | 0.26 | 0.36 | 0.80 | 1.44 | Upgrade
|
| Debt / FCF Ratio | 1.95 | 1.10 | 0.39 | 0.67 | 9.87 | - | Upgrade
|
| Asset Turnover | 0.94 | 0.99 | 1.01 | 0.99 | 0.77 | 0.83 | Upgrade
|
| Inventory Turnover | 0.87 | 1.07 | 1.10 | 1.14 | 0.95 | 1.34 | Upgrade
|
| Quick Ratio | 0.92 | 0.83 | 1.04 | 1.35 | 1.10 | 1.48 | Upgrade
|
| Current Ratio | 2.50 | 2.55 | 2.12 | 2.66 | 2.97 | 2.98 | Upgrade
|
| Return on Equity (ROE) | 29.65% | 31.98% | 40.24% | 36.25% | 17.54% | 12.88% | Upgrade
|
| Return on Assets (ROA) | 15.55% | 16.34% | 19.68% | 17.23% | 8.63% | 5.75% | Upgrade
|
| Return on Capital (ROIC) | 20.36% | 22.81% | 27.88% | 22.69% | 10.95% | 7.21% | Upgrade
|
| Earnings Yield | 5.03% | 5.30% | 10.37% | 3.70% | 2.91% | 2.91% | Upgrade
|
| FCF Yield | 2.10% | 1.85% | 9.71% | 2.64% | 0.36% | -2.59% | Upgrade
|
| Dividend Yield | 1.80% | 1.85% | 3.72% | 1.36% | 1.06% | 0.76% | Upgrade
|
| Payout Ratio | 34.21% | 40.54% | 25.55% | 13.80% | 15.89% | 11.25% | Upgrade
|
| Buyback Yield / Dilution | 0.51% | 3.50% | -0.03% | -0.37% | -7.73% | Upgrade
| |
| Total Shareholder Return | 1.80% | 2.37% | 7.22% | 1.33% | 0.69% | -6.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.